SUGAMMADEX Ideogen sol inj 200 mg/2ml 10 x 2 ml

7680685940018 CH-68594 V03AB35 15.01.0.
SUGAMMADEX Ideogen sol inj 200 mg/2ml 10 x 2 ml
SUGAMMADEX Ideogen sol inj 200 mg/2ml 10 x 2 ml
SUGAMMADEX Ideogen sol inj 200 mg/2ml 10 x 2 ml
1 / 3
google

Details

Product number
6859401
CPT
-
Packaging group
10 x 2 ml
Unit
Durchstechflasche(n)
Composition
sugammadexum 200 mg ut sugammadexum natricum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile ad solutionem pro 2 ml corresp. natrium 18.66 mg.

Articles (1)

Sugammadex Ideogen 200 mg / 2 ml, Injektionslösung
Injektionslösung
10 x 2 ml
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
09/01/2025
Professional SmPC
Français
09/01/2025
Professional SmPC
Italien
09/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
18.66 MG Substance HBESI

Authorization holder

IDEOGEN AG

8807 Freienbach

Authorization information

Swissmedic authorization number
68594
Drug name
Sugammadex Ideogen, Injektionslösung
Galenic form
LSINJ
ATC Code
V03AB35
Authorization status
Z
Dispensation category
B
First authorization
03/11/2023
Authorization expiration date
02/11/2028
IT number
15.01.0.
Domain
Human medicine
Field of application
Aufhebung der durch Recuronium oder Vecuronium induzierten neuromuskulären Blockade

Packaging details

Description (FR)
SUGAMMADEX Ideogen sol inj 200 mg/2ml 10 x 2 ml
Description (DE)
SUGAMMADEX Ideogen Inj Lös 200 mg/2ml 10 x 2 ml
Market launch
03/11/2023
Narcotic (BTM)
No

Other packaging sizes

SUGAMMADEX Ideogen sol inj 500 mg/5ml 10 x 5 ml
10 x 5 ml DUR
View